SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-004414
Filing Date
2022-02-09
Accepted
2022-02-09 16:30:54
Documents
13
Period of Report
2022-02-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glto-8k_20220203.htm   iXBRL 8-K 49927
2 EX-10.1 - AMENDED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY glto-ex101_7.htm EX-10.1 40305
  Complete submission text file 0001564590-22-004414.txt   228956

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA glto-20220203.xsd EX-101.SCH 5673
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE glto-20220203_lab.xml EX-101.LAB 20375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glto-20220203_pre.xml EX-101.PRE 12025
7 EXTRACTED XBRL INSTANCE DOCUMENT glto-8k_20220203_htm.xml XML 3674
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39655 | Film No.: 22607654
SIC: 2834 Pharmaceutical Preparations